Andrew Hamer

Directeur Technique/Scientifique/R&D chez CARDIOL THERAPEUTICS INC.

Fortune : 627 176 $ au 31/05/2024

62 ans

Health Technology

Consumer Services

Postes actifs de Andrew Hamer

Sociétés	Poste	Début	Fin
CARDIOL THERAPEUTICS INC.	Directeur Technique/Scientifique/R&D	29/03/2021	-

Sociétés	Poste	Début	Fin
AMGEN INC.	Corporate Officer/Principal	01/01/2018	01/03/2021
CAPRICOR THERAPEUTICS, INC.	Directeur Technique/Scientifique/R&D	22/11/2013	30/07/2015
Capricor, Inc. Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013.	Directeur Technique/Scientifique/R&D	01/11/2013	-

University of Otago

Undergraduate Degree

Internationale

Opérationnelle

Chief Tech/Sci/R&D Officer	3
Undergraduate Degree	1
Corporate Officer/Principal	1

Sectorielle

Health Technology	5
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	1
Capricor, Inc. Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013.	Health Technology

Entreprise privées

Health Technology